CytoDyn Appoints Denis R. Burger, Ph.D. To Board Of Directors
2/13/2014 10:04:17 AM
VANCOUVER, Wash.--(BUSINESS WIRE)--CytoDyn Inc. (OTCQB: CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced the appointment of Denis R. Burger, Ph.D. to its Board of Directors effective February 7, 2014. Dr. Burger is a life sciences executive with over 25 years of extensive scientific, operational and financial experience in the biotech industry.
Help employers find you! Check out all the jobs and post your resume.
comments powered by